Back to search

A phase III randomized trial of intensive induction and consolidation chemotherapy ± oblimersen, a pro-apoptotic Bcl-2 antisense oligonucleotide in untreated acute myeloid leukemia patients >60 years old

Guido Marcucci, Barry Kurt Moser, William Blum, Wendy Stock, Meir Wetzler
DOI: 10.1200/jco.2007.25.18_suppl.7012
Journal of Clinical Oncology

Data up to Jan 2025

Published2007
Citations59
References0
Fields
MedicineBiologyInternal medicineOncologyGastroenterology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
A phase III randomized trial of intensive induction and consolidation chemotherapy ±… (2007) – Journal of Clinical Oncology | Metascience Observatory Explorer